Physician profile
Todd M Morgan
NPI 1356452684
$34,279.29
in general payments reported to CMS, 2019-2025
11 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,466 · 2020: $1,750 · 2021: $2,500 · 2022: $891 · 2023: $6,976 · 2024: $7,085 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,775.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,620.00 |
| Food and Beverage | $277.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13,799.09 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $7,725.00 | 2024-2025 | Keytruda |
| Foundation Medicine, INC. | $6,976.00 | 2023 | |
| Blue Earth Diagnostics | $2,650.00 | 2019-2020 | |
| Janssen Global Services, LLC | $1,550.00 | 2025 | Rybrevant |
| Janssen Scientific Affairs, LLC | $757.50 | 2022 | |
| Genzyme Corporation | $565.72 | 2019 | |
| Edap Technomed INC | $133.08 | 2022 | |
| Tempus Ai, INC | $100.86 | 2025 | Xt Cdx |
| Astellas Pharma US INC | $22.04 | 2025 | Veozah |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.